Health Faricimab Shows Promising Results in nAMD and PCV Trials Results from clinical trials involving faricimab (marketed as Vabysmo) have indicated significant progress in treating neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy... Editorial13 hours ago